These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1119513)

  • 1. Letter: Serum testosterone in the polycystic ovary syndrome.
    Givens JR; Andersen RN
    Am J Obstet Gynecol; 1975 Apr; 121(8):1124-5. PubMed ID: 1119513
    [No Abstract]   [Full Text] [Related]  

  • 2. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
    Daane TA; Dignam WJ; Frankland MV; Simmer HH; Parlow AF
    Am J Obstet Gynecol; 1973 Oct; 117(3):392-9. PubMed ID: 4729733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.
    Givens JR; Andersen RN; Wiser WL; Fish SA
    J Clin Endocrinol Metab; 1974 May; 38(5):727-35. PubMed ID: 4823918
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hilus cell pathology and hirsutism.
    McLellan AR; Mowat A; Cordiner J; Beastall GH; Wallace AM; Connell JM; Davies DL
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):203-12. PubMed ID: 2112066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women.
    Givens JR; Andersen RN; Wiser WL; Umstot ES; Fish SA
    Am J Obstet Gynecol; 1976 Feb; 124(4):333-9. PubMed ID: 1251854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relations between polycystic ovary and idiopathic hirsutism].
    Montesanti F; Rama GP; Francia G; Adami S; Lo Cascio V
    G Clin Med; 1988 Mar; 69(3):183-5. PubMed ID: 2971587
    [No Abstract]   [Full Text] [Related]  

  • 8. Leuprolide suppression of androgen secretion by hilus cell hyperplasia within the wall of an ovarian cyst.
    de Santiago M; Herranz L; Ordas J; Atienza M; Suarez-Mier M; Gancedo PG
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):239-42. PubMed ID: 8881459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
    Adams J; Polson DW; Franks S
    Br Med J (Clin Res Ed); 1986 Aug; 293(6543):355-9. PubMed ID: 3089520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
    Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
    Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of normal ovarian physiology by exogenous gondaotropin stimulation following steroid pituitary suppression.
    Jones GS; De Moraes Ruehsen M; Johanson AJ; Raiti S; Bilzzard RM
    Fertil Steril; 1969; 20(1):14-34. PubMed ID: 5762550
    [No Abstract]   [Full Text] [Related]  

  • 13. Hirsutism and polycystic ovary syndrome.
    Givens JR; Goodman RC
    Hosp Pract (Off Ed); 1986 Oct; 21(10A):81-4, 87-9, 93-4 passim. PubMed ID: 3095345
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperthecosis: an inheritable form of polycystic ovarian disease.
    Wilroy RS; Givens JR; Wiser WL; Coleman SA; Andersen RN; Summitt RL
    Birth Defects Orig Artic Ser; 1975; 11(4):81-5. PubMed ID: 1156689
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated free testosterone in an obese, hirsute premenarchial girl: effects of norethynodrel and mestranol.
    Haymond MW; Bussmann Y; Wiest WG
    Pediatrics; 1979 Nov; 64(5):609-12. PubMed ID: 573879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
    Fulghesu AM; Angioni S; Belosi C; Apa R; Selvaggi L; Ciampelli M; Iuculano A; Melis GB; Lanzone A
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monocystic ovary syndrome.
    Delahunt JW; Clements RV; Ramsay ID; Newton J; Collins WP; Landon J
    Br Med J; 1975 Dec; 4(5997):621-2. PubMed ID: 1203702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
    Givens JR; Andersen RN; Ragland JB; Wiser WL; Umstot ES
    J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of testosterone and androstenedione porduction rates with dexamethasone in women with idiopathic hirsutsm and polycystic ovaries.
    Bardin CW; Hembree WC; Lipsett MB
    J Clin Endocrinol Metab; 1968 Sep; 28(9):1300-6. PubMed ID: 4300558
    [No Abstract]   [Full Text] [Related]  

  • 20. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
    J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.